Ongoing Research and Development Activities
First written in FY2017-Q1. 20 of 28 entries say "Restated". Latest entry: FY2026.
45 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Under Vision2030, “Be the best SPICE! ~Become the ultimate spice that excites the senses~,” the R&D Division is advancing the development of SPICE products through 2 groups: the Digital Solution Material Group, which develops high-performance materials for an advanced digital society, and the Essential Material Group, which develops chemicals essential to a sustainable society. Total R&D expenses for the fiscal year amounted to ¥919 million.」
The R&D organization has been consolidated into 2 groups, Digital and Essential, with specific development projects including RiKAiJAST and acid dianhydrides for photosensitive polyimide. R&D expenses amounted to ¥919 million. - FY2025AdvancedAnnual report
「Total R&D expenses for the fiscal year amounted to ¥946 million. As the Group operates in a single segment, segment-specific disclosures have been omitted.」
R&D expenses increased from ¥848 million in the previous fiscal year to ¥946 million. The R&D infrastructure has also taken concrete shape through the introduction of ICP-MS, joint development with universities, conversion of the Kyoto R&D Center’s yellow room and completion of a 50-liter pilot facility. - FY2024AdvancedAnnual report
「Total R&D expenses for the fiscal year amounted to ¥848 million. As the Group operates in a single segment, segment-specific disclosures have been omitted.」
The company recorded R&D expenses of ¥848 million, narrowed its research themes to 4 priority areas, and advanced specific development and adoption activities involving RiKACRYSTA, biomass-derived esters and special acid dianhydrides. - FY2024-Q2RestatedAnnual report
「Total R&D expenses for the six-month period ended 30 September amounted to ¥436 million. There were no material changes in the status of the Group’s R&D activities during the six-month period ended 30 September.」
The company continues to state that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥436 million. - FY2024-Q1RestatedAnnual report
「Total R&D expenses for the three-month period ended 30 June amounted to ¥230 million. There were no material changes in the status of the Group’s R&D activities during the three-month period ended 30 June.」
The company continues to state that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥230 million for the first quarter. - FY2023-Q3RestatedAnnual report
「Total R&D expenses for the nine-month period ended 31 December amounted to ¥657 million. There were no material changes in the status of the Group’s R&D activities during the nine-month period ended 31 December.」
The company states that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥657 million. - FY2023-Q2RestatedAnnual report
「Total R&D expenses for the six-month period ended 30 September amounted to ¥462 million. There were no material changes in the status of the Group’s R&D activities during the six-month period ended 30 September.」
The company states that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥462 million. - FY2023-Q1ReframedAnnual report
「The company is advancing reforms to its R&D processes, including concentrating development resources in fields that address environmental issues.」
The focus is shifting from continuing conventional R&D activities to concentrating development resources on environmental issues and reforming the R&D process. - FY2022-Q3RestatedAnnual report
「Total R&D expenses for the nine-month period ended 31 December amounted to ¥603 million. There were no material changes in the status of the Group’s R&D activities during the nine-month period ended 31 December.」
The company states that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥603 million. - FY2022-Q2AdvancedAnnual report
「At the Kyoto R&D Center, which opened in May this year, the company is developing biomass plasticizers and 100% plant-derived ester oils to strengthen its approach to environmental issues.」
The Kyoto R&D Center, which had been under construction, opened in May, and the company has moved into the stage of developing biomass plasticizers and 100% plant-derived ester oils. - FY2022-Q1RestatedAnnual report
「Total R&D expenses for the three-month period ended 30 June amounted to ¥191 million. There were no material changes in the status of the Group’s R&D activities during the three-month period ended 30 June.」
The company continues to state that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥191 million. - FY2021-Q2RestatedAnnual report
「Total R&D expenses for the six-month period ended 30 September amounted to ¥340 million. There were no material changes in the status of the Group’s R&D activities during the six-month period ended 30 September.」
The company continues to state that there have been no material changes in its R&D activities and has disclosed R&D expenses of ¥340 million. - FY2021-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥178 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
Continues to state that there were no material changes in R&D activities and discloses R&D expenses of ¥178 million. - FY2020AdvancedAnnual report
「Going forward, toward completion of the Kyoto R&D Center currently under construction in the Keihanna area, the company will respond swiftly to market changes and seek to create next-generation, high-value-added products at an early stage by generating R&D themes unconstrained by conventional frameworks and concentrating research resources on priority development themes.」
The company has progressed to the stage of pursuing the early creation of next-generation products by constructing the Kyoto R&D Center, generating R&D themes, and concentrating resources on priority themes. R&D expenses are ¥730 million. - FY2020-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥555 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
Continues to state that there were no material changes in R&D activities and discloses R&D expenses of ¥555 million. - FY2020-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥362 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
Continues to state that there were no material changes in R&D activities and discloses R&D expenses of ¥362 million for the second quarter of the current consolidated cumulative period. - FY2020-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥179 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
Continues to state that there were no material changes in R&D activities and discloses first-quarter R&D expenses of ¥179 million. - FY2019-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥554 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses R&D expenses of ¥554 million. - FY2019-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥366 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses R&D expenses of ¥366 million for the second quarter of the current consolidated cumulative period. - FY2019-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥185 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses first-quarter R&D expenses of ¥185 million. - FY2018RestatedAnnual report
「Total R&D expenses for the current consolidated fiscal year were ¥719 million. As the Group operates as a single segment, segment-by-segment information has been omitted.」
Continues its R&D activities and discloses R&D expenses of ¥719 million for the current consolidated fiscal year. - FY2018-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥530 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses R&D expenses of ¥530 million. - FY2018-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥351 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses R&D expenses of ¥351 million. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥160 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses first-quarter R&D expenses of ¥160 million. - FY2017AdvancedAnnual report
「The research and sales teams in each business division are working together to quickly and accurately identify customer needs. The company has established a framework in which the business divisions strongly lead new product development by building a cooperative structure among related departments, thereby accelerating development. It has also strengthened its manufacturing research institute, which supports pilot production and scale-up studies for products under development, and is promoting development activities aimed at earning customer trust at an early stage.」
For R&D, the company is integrating the business division and sales functions, supporting pilot production and scale-up studies, and strengthening its manufacturing research institute, with R&D expenses of ¥730 million recorded. - FY2017-Q3RestatedAnnual report
「Total R&D expenses for the third quarter of the current consolidated cumulative period were ¥541 million. There were no material changes in the status of the Group's R&D activities during the third quarter of the current consolidated cumulative period.」
Continues the policy of stating that there were no material changes in R&D activities and discloses R&D expenses of ¥541 million. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the second quarter of the current consolidated cumulative period were ¥357 million. There were no material changes in the status of the Group's R&D activities during the second quarter of the current consolidated cumulative period.」
Discloses R&D expenses of ¥357 million for the second quarter of the current consolidated cumulative period and states that there were no material changes in R&D activities. - FY2017-Q1First statedAnnual report
「Total R&D expenses for the first quarter of the current consolidated cumulative period were ¥176 million. There were no material changes in the status of the Group's R&D activities during the first quarter of the current consolidated cumulative period.」
Reports R&D expenses for the quarter and states that there were no material changes in R&D activities.